| NDC Code | 58160-806-05 |
|---|
| Package Description | 10 VIAL in 1 CARTON (58160-806-05) > .5 mL in 1 VIAL (58160-806-01) |
|---|
| Product NDC | 58160-806 |
|---|
| Product Type Name | VACCINE |
|---|
| Proprietary Name | Hiberix |
|---|
| Non-Proprietary Name | Haemophilus B Conjugate Vaccine (tetanus Toxoid Conjugate) |
|---|
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
|---|
| Usage | INTRAMUSCULAR |
|---|
| Start Marketing Date | 20090824 |
|---|
| Marketing Category Name | BLA |
|---|
| Application Number | BLA125347 |
|---|
| Manufacturer | GlaxoSmithKline Biologicals SA |
|---|
| Substance Name | HAEMOPHILUS INFLUENZAE TYPE B STRAIN 20752 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN |
|---|
| Strength | 10 |
|---|
| Strength Unit | ug/.5mL |
|---|
| Pharmacy Classes | Inactivated Haemophilus Influenzae B Vaccine [EPC],Actively Acquired Immunity [PE],Haemophilus Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient] |
|---|